Marc Güell

Marc is the non-executive Scientific Director of S-Biomedic. Currently, he is a tenure-track professor at Pompeu Fabra University.

His laboratory is focused on leveraging new gene editing technologies for therapeutic purposes. The two main lines of research there are mammalian genome engineering and microbiome engineering.

Previously, Marc was a Wyss Technology Development Fellow at the Wyss Institute (mentor: George Church, Harvard Medical School). While there, he developed gene editing technologies to create bio contained safe recoded microorganisms as well as engineered pigs for xenotransplantation.

A substantial part of his career has been spent in translational science. In addition to S-Biomedic, Marc is also the founding scientist of eGenesis, a company striving to provide an unlimited source of organs for transplantation.